TNC and non-small cell lung carcinoma: Tenascin-C concentration in NSCLC-patients was significantly elevated (n=103, mean 5.5 ng/ml, standard deviation (SD) ±3.8 ng/ml) compared to healthy blood donors (n=76, mean 6.3/ml, SD ±6.6ng/ml, p=0.013; Figure 1A).